← Back to Clinical Trials
Recruiting NCT06683248

NCT06683248 The Effects of Night Shift Work on Health Across the Menstrual Cycle

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06683248
Status Recruiting
Phase
Sponsor Uppsala University
Condition Sleep Deprivation
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2022-04-25
Primary Completion 2024-12-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Investigate sleep deprivation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2022-04-25 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study aims to investigate the effects of sleep deprivation on women's health across different phases of the menstrual cycle.

Eligibility Criteria

Inclusion Criteria: \- Healthy Exclusion Criteria: * Use of hormonal contraceptives * Chronic disease * Regular use of nicotine * Use of medication * Consumes excessive amounts of alcohol or coffee

Contact & Investigator

Central Contact

Christian Benedict, PhD

✉ christian.benedict@farmbio.uu.se

📞 +4618-471 4148

Frequently Asked Questions

Who can join the NCT06683248 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Sleep Deprivation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06683248 currently recruiting?

Yes, NCT06683248 is actively recruiting participants. Contact the research team at christian.benedict@farmbio.uu.se for enrollment information.

Where is the NCT06683248 trial being conducted?

This trial is being conducted at Uppsala, Sweden.

Who is sponsoring the NCT06683248 clinical trial?

NCT06683248 is sponsored by Uppsala University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology